Bruehlman Ronald E 4
4 · GoodRx Holdings, Inc. · Filed May 29, 2026
Research Summary
AI-generated summary of this filing
GoodRx (GDRX) Director Ronald Bruehlman Receives Award
What Happened Ronald E. Bruehlman, a director of GoodRx Holdings, Inc. (GDRX), was granted 4,642 deferred stock units on May 27, 2026. The units were reported at $0 per unit (transaction code A — award/grant), so the filing shows $0 as the acquisition price/value. This was a compensation award rather than an open‑market purchase or sale.
Key Details
- Transaction date and price: 2026-05-27, award of 4,642 units at $0.00 each (code A).
- Filed with SEC: Form 4 filed 2026-05-29 for the 2026-05-27 transaction (appears timely).
- Shares owned after transaction: Not disclosed in the provided filing excerpt.
- Footnote (F1): These are deferred stock units (each unit = contingent right to one Class A share). Vesting: 2% of the underlying shares vest on May 31, 2026; the remaining 98% vest in substantially equal monthly installments on the last day of each month over the next 7 months, subject to continued service. Settlement occurs on the earliest of (i) Dec 31, 2031; (ii) separation from service; (iii) change in control; (iv) death; or (v) disability, per the company’s Deferred Compensation Plan for Directors.
Context Deferred stock units are a form of compensation and represent a future contingent right to receive shares if vesting/settlement conditions are met. Awards like this reflect director compensation and are not the same signal as an open‑market buy or sell by an insider.
Insider Transaction Report
Form 4
Bruehlman Ronald E
Director
Transactions
- Award
Class A Common Stock
[F1]2026-05-27+4,642→ 133,918 total
Footnotes (1)
- [F1]Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest as to 2% of the underlying shares on May 31, 2026, and the remining 98% will vest in substantially equal monthly installments on last day of each month over the following 7 months, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2031; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Ronald E Bruehlman|2026-05-29